ACLU Sues to End West Virginia Methadone Clinic Moratorium

A federal lawsuit is challenging West Virginia’s nearly two-decade ban on new methadone clinics, and a local recovery specialist in Beckley is weighing in with concerns that reflect a broader national debate about the role of methadone in opioid use disorder treatment.

West Virginia’s largest overdose prevention group, Solutions Oriented Addiction Response of West Virginia (SOAR-WV), filed the lawsuit in the U.S. District Court for the Southern District of West Virginia, represented by the ACLU of West Virginia, the national ACLU, and the law firm Kaplan & Grady.

The suit argues that the moratorium constitutes disability discrimination and demands that the state allow new opioid treatment programs to open.

Why Methadone Clinics Matter for Opioid Detox

West Virginia is the only state in the nation with a moratorium on new methadone clinics, a stark distinction for a state that has led the nation in overdose deaths for nearly 15 years. Since 2008, nearly 12,000 people have died of an opioid overdose there.

The moratorium has left only nine clinics operating statewide, with broad swaths of the population more than an hour’s drive from the nearest facility.

Because methadone treatment programs typically require daily in-person check-ins, that distance makes it practically impossible for thousands of West Virginians to access treatment while managing work and family obligations.

Methadone is a full opioid agonist, meaning it fully activates the brain’s opioid receptors, which makes it uniquely effective for people with severe opioid use disorder, particularly those dependent on fentanyl.

SOAR co-director Sarah Stone explained that methadone allows people using powerful opioids like fentanyl to begin recovery treatment without first enduring painful and potentially dangerous withdrawal symptoms, which can dramatically increase the risk of relapse and death.

Fifty years of scientific research has shown that methadone cuts the risk of death from all causes, including overdose, in half. It reduces illicit drug use, decreases infectious disease transmission, and improves quality of life.

A Local Recovery Specialist Has Reservations

Not everyone in the West Virginia recovery community supports expanding methadone access. Vanessa Smith, Administrative Director of The Storehouse, a recovery facility in Beckley, told 59News she has concerns about the drug’s effects on patients.

“What they’re trying to do with the methadone is lower the overdose rate in our state, understandable,” Smith said. “But it is not treatment. The effects of methadone: it causes you to be numb inside, tired, slumberish, sluggish.”

Smith’s perspective is one heard frequently in peer-based and abstinence-oriented recovery communities. It reflects a genuine tension in addiction medicine between two valid goals: reducing overdose deaths immediately versus achieving full abstinence over time.

Addiction medicine specialists and federal health authorities, however, are clear that both goals can coexist, and that withholding medication-assisted treatment does not improve long-term outcomes. The clinical and scientific consensus is that methadone is an evidence-based medication, not simply a substitute drug.

Understanding Methadone as Medication-Assisted Treatment

Methadone is one of three FDA-approved medications for opioid use disorder, alongside buprenorphine (Suboxone) and naltrexone (Vivitrol). It is a highly regulated controlled substance dispensed exclusively through federally licensed opioid treatment programs (OTPs).

Patients receive their dose under clinical supervision, typically daily at first, and must also participate in counseling and undergo regular drug testing as part of a structured treatment plan.

Unlike buprenorphine, which can be prescribed in office-based settings, methadone for opioid use disorder must be dispensed daily through a federally regulated opioid treatment program. This creates significant access barriers, especially in rural states like West Virginia.

The sedation and fatigue that Smith describes are real side effects, most common during the dose-stabilization phase, and are addressed through careful clinical titration.

They are not a permanent feature of medically managed methadone treatment, and they are far preferable, clinically speaking, to active opioid dependence or untreated withdrawal.

The Legal Argument for Expanding Access

The lawsuit argues the moratorium violates Title II of the Americans with Disabilities Act and Section 504 of the Rehabilitation Act.

ACLU Staff Attorney Joseph Longley explained that people seeking health services in connection with drug rehabilitation are considered people with disabilities under federal law, and that the government should not be blocking access to lifesaving care.

The suit also challenges a separate state zoning restriction that bars methadone clinics from operating within a half-mile of any daycare center or school, a rule that does not apply to any other type of healthcare facility.

Critics call this an example of the stigma attached to addiction treatment that does not follow evidence-based health policy.

Fentanyl Has Changed the Stakes

The fentanyl epidemic is central to the debate over methadone access. Buprenorphine may not be potent enough for some individuals using fentanyl, which now plays a far greater role in overdose deaths than heroin.

In West Virginia last year, fentanyl was involved in 1,126 of the state’s 1,383 overdose deaths, while heroin was linked to just eight.

That clinical reality underscores why addiction medicine specialists argue that eliminating access to one of the most effective medications available, in the state most ravaged by the opioid crisis, amounts to a public health emergency.

Finding Medication-Assisted Treatment in West Virginia

For people in West Virginia struggling with opioid use disorder, medically supervised detox is the safest first step. A physician or licensed opioid treatment program can evaluate whether methadone, buprenorphine or naltrexone is the most appropriate medication based on individual history, substance use patterns, and withdrawal severity.

Never attempt opioid detox without medical supervision, untreated withdrawal from fentanyl or other opioids can be life-threatening and significantly increases the risk of fatal overdose upon relapse.

Search detox.com’s directory of medical detox centers to start your treatment today. You can also call 800-996-6135(Sponsored) to speak with a treatment advisor.